These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 16459265

  • 1. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S, Vaidyanathan G, Kuan CT, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
    Shankar S, Vaidyanathan G, Affleck DJ, Peixoto K, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
    [Abstract] [Full Text] [Related]

  • 3. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
    Kuan CT, Reist CJ, Foulon CF, Lorimer IA, Archer G, Pegram CN, Pastan I, Zalutsky MR, Bigner DD.
    Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
    [Abstract] [Full Text] [Related]

  • 4. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.
    Foulon CF, Reist CJ, Bigner DD, Zalutsky MR.
    Cancer Res; 2000 Aug 15; 60(16):4453-60. PubMed ID: 10969792
    [Abstract] [Full Text] [Related]

  • 5. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
    Reist CJ, Garg PK, Alston KL, Bigner DD, Zalutsky MR.
    Cancer Res; 1996 Nov 01; 56(21):4970-7. PubMed ID: 8895752
    [Abstract] [Full Text] [Related]

  • 6. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
    Shankar S, Vaidyanathan G, Affleck D, Welsh PC, Zalutsky MR.
    Bioconjug Chem; 2003 Nov 01; 14(2):331-41. PubMed ID: 12643743
    [Abstract] [Full Text] [Related]

  • 7. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
    Reist CJ, Archer GE, Wikstrand CJ, Bigner DD, Zalutsky MR.
    Cancer Res; 1997 Apr 15; 57(8):1510-5. PubMed ID: 9108453
    [Abstract] [Full Text] [Related]

  • 8. Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma.
    Boskovitz A, Akabani GH, Pegram CN, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2004 Apr 15; 31(3):345-55. PubMed ID: 15028247
    [Abstract] [Full Text] [Related]

  • 9. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
    Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK, Wong AJ, Bigner DD, Zalutsky MR.
    Cancer Res; 1995 Oct 01; 55(19):4375-82. PubMed ID: 7671250
    [Abstract] [Full Text] [Related]

  • 10. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK.
    Nucl Med Biol; 2005 Feb 01; 32(2):157-64. PubMed ID: 15721761
    [Abstract] [Full Text] [Related]

  • 11. Nepsilon-(3-[*I]Iodobenzoyl)-Lys5-Nalpha-maleimido-Gly1-GEEEK ([*I]IB-Mal-D-GEEEK): a radioiodinated prosthetic group containing negatively charged D-glutamates for labeling internalizing monoclonal antibodies.
    Vaidyanathan G, Alston KL, Bigner DD, Zalutsky MR.
    Bioconjug Chem; 2006 Feb 01; 17(4):1085-92. PubMed ID: 16848419
    [Abstract] [Full Text] [Related]

  • 12. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G, Booth BJ, Batra SK, Colcher D.
    Clin Cancer Res; 1999 Sep 01; 5(9):2613-9. PubMed ID: 10499640
    [Abstract] [Full Text] [Related]

  • 13. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
    Zalutsky MR, Noska MA, Colapinto EV, Garg PK, Bigner DD.
    Cancer Res; 1989 Oct 15; 49(20):5543-9. PubMed ID: 2477144
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P, Cameron R, Wang J, Vallis KA, Reilly RM.
    J Nucl Med; 2003 Sep 15; 44(9):1469-78. PubMed ID: 12960194
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy of human glioma xenografts with unlabeled, 131I-, or 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor.
    Bender H, Takahashi H, Adachi K, Belser P, Liang SH, Prewett M, Schrappe M, Sutter A, Rodeck U, Herlyn D.
    Cancer Res; 1992 Jan 01; 52(1):121-6. PubMed ID: 1727372
    [Abstract] [Full Text] [Related]

  • 16. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
    Choi CW, Lang L, Lee JT, Webber KO, Yoo TM, Chang HK, Le N, Jagoda E, Paik CH, Pastan I.
    Cancer Res; 1995 Nov 15; 55(22):5323-9. PubMed ID: 7585595
    [Abstract] [Full Text] [Related]

  • 17. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar 15; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 18. Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
    Sato N, Hassan R, Axworthy DB, Wong KJ, Yu S, Theodore LJ, Lin Y, Park L, Brechbiel MW, Pastan I, Paik CH, Carrasquillo JA.
    J Nucl Med; 2005 Jul 15; 46(7):1201-9. PubMed ID: 16000290
    [Abstract] [Full Text] [Related]

  • 19. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
    Schuster JM, Garg PK, Bigner DD, Zalutsky MR.
    Cancer Res; 1991 Aug 15; 51(16):4164-9. PubMed ID: 1714341
    [Abstract] [Full Text] [Related]

  • 20. Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands.
    Hens M, Vaidyanathan G, Welsh P, Zalutsky MR.
    Nucl Med Biol; 2009 Feb 15; 36(2):117-28. PubMed ID: 19217523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.